Tumor-specific CD4+ and CD8+ T cells migrate to the tumor site, and CTLs induce cell lysis and/or apoptosis in antigen-bearing tumor cells through the release of perforin and granzymes or by a Fas/Fas ligand interaction. The gene discussed is CD8A; the disease is neoplasm.